DORENDA LEWIS: Open Payments
NPI 1407197841 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$389 in 18 payments from 10 companies in 2025. Trend: 2023 $70 · 2024 $138 · 2025 $389
Food & beverage: $389
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 3 | $77 |
| Lilly USA, LLC | 4 | $71 |
| Xeris Pharmaceuticals, Inc. | 3 | $65 |
| Amgen Inc. | 2 | $48 |
| AstraZeneca Pharmaceuticals LP | 1 | $31 |
| Ultragenyx Pharmaceutical Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $21 |
| KYOWA KIRIN, INC. | 1 | $20 |
| PFIZER INC. | 1 | $19 |
| Ascendis Pharma Endocrinology Inc | 1 | $16 |
Products named: Cologuard Collection Kit, GVOKE HYPOPEN, MOUNJARO, REPATHA, CRYSVITA, FLUMIST QUADRIVALENT, PREVNAR 20, ZEPBOUND.
Industry payments across IL — which companies pay providers there.
